The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell ...

Paolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for ...

Panelists discuss how a 48-year-old fitness instructor with ALK-rearranged stage IV lung cancer and bone metastases was ...

While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...

Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

Panelists discuss updated MonumenTAL-1 trial data demonstrating high response rates and prolonged survival with ...

Panelists discuss updated safety findings from GPRC5D-targeted bispecific therapy in relapsed/refractory multiple myeloma, ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

Panelists discuss how patient portal use improves communication by allowing patients to report adverse effects with photos ...

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Oncology nurses can assess patients’ risk factors and advocate for preventive strategies that protect kidney function during ...